Medical Hypotheses
Volume 73, Issue 6 , Pages 1053-1054, December 2009

Cortistatin vaccination – A solution to growth hormone deficiency

  • M. Moaeen-ud-Din

      Affiliations

    • Functional Genomics Lab, University of Veterinary and Animal Sciences, Lahore, Pakistan
    • China Education Ministry’s Key Laboratory of Animal Breeding, Genetics and Reproduction, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, PR China
    • These authors contributed equally to this work.
    • Corresponding Author InformationCorresponding author. Address: Functional Genomics Lab, University of Veterinary and Animal Sciences, Lahore, Pakistan. Tel.: +92 34 38702054.
  • ,
  • Nosheen Malik

      Affiliations

    • Functional Genomics Lab, University of Veterinary and Animal Sciences, Lahore, Pakistan
    • These authors contributed equally to this work.
  • ,
  • Yang Li Guo

      Affiliations

    • China Education Ministry’s Key Laboratory of Animal Breeding, Genetics and Reproduction, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, PR China
  • ,
  • Ahmad Ali

      Affiliations

    • Functional Genomics Lab, University of Veterinary and Animal Sciences, Lahore, Pakistan
  • ,
  • Masroor Ellahi Babar

      Affiliations

    • Functional Genomics Lab, University of Veterinary and Animal Sciences, Lahore, Pakistan

Received 17 March 2009; accepted 20 May 2009. published online 29 June 2009.

Summary 

Cortistatin and somatostatin are neuropeptides which have inhibitory effects on growth hormone through common five receptors. Although, both have inhibitory effects but, only cortistatin has direct inhibitory effects on growth hormone secretagogue and is more potent inhibitor of growth hormone than somatostatin. This control of growth hormone can be manipulated through immunoneutralization of cortistatin through cortistatin DNA vaccine rather than antibodies application. A DNA vaccine of cortistatin can be produced using recombinant DNA technology in a eukaryotic expression system and will serve as a tool not to only alleviate the growth hormone deficiency problems in human but, can also be used to improve growth rate in farm animals.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-9877(09)00355-7

doi:10.1016/j.mehy.2009.05.020

Medical Hypotheses
Volume 73, Issue 6 , Pages 1053-1054, December 2009